Migraine With Or Without Aura Susceptibility To 6 C1843765
Migraines are severe headaches that may or may not be preceded by aura symptoms such as flashing lights or tingling. Genetic predisposition plays a role in developing this condition. Treatment combines trigger avoidance, preventive therapy, and pain relief during attacks.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Photophobia
(neurologic)Nausea
(neurologic)Phonophobia
(neurologic)Visual aura
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Regular exercise and cardiovascular fitness
Moderate regular aerobic exercise such as walking, swimming, or cycling helps reduce migraine frequency by releasing endorphins and reducing stress hormones. Start gradually and maintain consistency for optimal benefit.
Migraine prevention pharmacotherapy
Prophylactic medications including certain antihypertensives, antidepressants, or anticonvulsants may be prescribed for frequent migraines. These medications are taken regularly to reduce attack frequency and severity rather than during acute episodes.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Migraine With Or Without Aura Susceptibility To 6 C1843765?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Lipton RB, Silberstein SD, Dodick DW, et al. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Cephalalgia. 2022.
Puledda F, Shields K, O'Daly J. Migraine with and without aura: understanding the pathophysiology and clinical management. Neurology. 2020.
Karsan N, Bose PR, Newman J, Afshari D. Calcitonin gene-related peptide targeted therapies for migraine prevention: a systematic review and meta-analysis. Headache. 2021.
Ashina S, Terband I, Mehle A, et al. Randomized controlled trial of erenumab for migraine prevention in patients with migraine and aura. BMJ Open. 2023.
Medication Comparisons
Compare medications used to treat Migraine With Or Without Aura Susceptibility To 6 C1843765. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy